Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Prognostic impact of the combination of erythropoiesis-stimulating agents to cancer treatment: literature review.

Boulaamane L, Goncalves A, Boutayeb S, Viens P, M'rabti H, Bertucci F, Errihani H.

Support Care Cancer. 2013 Aug;21(8):2359-69. doi: 10.1007/s00520-013-1866-8. Epub 2013 Jun 18. Review.

PMID:
23775155
[PubMed - indexed for MEDLINE]
2.

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes.

Glaspy J, Crawford J, Vansteenkiste J, Henry D, Rao S, Bowers P, Berlin JA, Tomita D, Bridges K, Ludwig H.

Br J Cancer. 2010 Jan 19;102(2):301-15. doi: 10.1038/sj.bjc.6605498. Epub 2010 Jan 5.

PMID:
20051958
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses.

Vansteenkiste J, Glaspy J, Henry D, Ludwig H, Pirker R, Tomita D, Collins H, Crawford J.

Lung Cancer. 2012 Jun;76(3):478-85. doi: 10.1016/j.lungcan.2011.12.015. Epub 2012 Jan 25.

PMID:
22277104
[PubMed - indexed for MEDLINE]
Free Article
4.

Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data.

Bohlius J, Tonia T, Nüesch E, Jüni P, Fey MF, Egger M, Bernhard J.

Br J Cancer. 2014 Jul 8;111(1):33-45. doi: 10.1038/bjc.2014.171. Epub 2014 Apr 17. Review.

PMID:
24743705
[PubMed - indexed for MEDLINE]
5.

Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer.

Aapro M, Jelkmann W, Constantinescu SN, Leyland-Jones B.

Br J Cancer. 2012 Mar 27;106(7):1249-58. doi: 10.1038/bjc.2012.42. Epub 2012 Mar 6. Review.

PMID:
22395661
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data.

Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke MJ, Weingart O, Kluge S, Piper M, Napoli M, Rades D, Steensma D, Djulbegovic B, Fey MF, Ray-Coquard I, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007303. doi: 10.1002/14651858.CD007303.pub2. Review.

PMID:
19588423
[PubMed - indexed for MEDLINE]
7.

Twist and shout: one decade of meta-analyses of erythropoiesis-stimulating agents in cancer patients.

Bohlius J, Tonia T, Schwarzer G.

Acta Haematol. 2011;125(1-2):55-67. doi: 10.1159/000318897. Epub 2010 Dec 8. Review.

PMID:
21150188
[PubMed - indexed for MEDLINE]
Free Article
8.

Erythropoiesis-stimulating agents for anemic patients with cancer.

Sheikh S, Littlewood TJ.

Expert Rev Hematol. 2010 Dec;3(6):697-704. doi: 10.1586/ehm.10.64. Review.

PMID:
21091146
[PubMed - indexed for MEDLINE]
9.

Erythropoiesis-stimulating agents in cancer patients: reflections on safety.

Wauters I, Vansteenkiste J.

Expert Rev Clin Pharmacol. 2011 Jul;4(4):467-76. doi: 10.1586/ecp.11.22. Review.

PMID:
22114856
[PubMed - indexed for MEDLINE]
10.

Erythropoiesis-stimulating agents (ESAs): do they still have a role in chemotherapy-induced anemia (CIA)?

Bormanis J, Quirt I, Chang J, Kouroukis CT, MacDonald D, Melosky B, Verma S, Couture F.

Crit Rev Oncol Hematol. 2013 Aug;87(2):132-9. doi: 10.1016/j.critrevonc.2012.12.010. Epub 2013 Jan 26. Review.

PMID:
23357249
[PubMed - indexed for MEDLINE]
11.

Update on erythropoiesis-stimulating agents and clinical trials in oncology.

Aapro M, Spivak JL.

Oncologist. 2009;14 Suppl 1:6-15. doi: 10.1634/theoncologist.2009-S1-6. Review.

PMID:
19762512
[PubMed - indexed for MEDLINE]
Free Article
12.

Management of anemia in cancer patients.

Calabrich A, Katz A.

Future Oncol. 2011 Apr;7(4):507-17. doi: 10.2217/fon.11.24. Review.

PMID:
21463140
[PubMed - indexed for MEDLINE]
13.

A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.

Wilson J, Yao GL, Raftery J, Bohlius J, Brunskill S, Sandercock J, Bayliss S, Moss P, Stanworth S, Hyde C.

Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. Review.

PMID:
17408534
[PubMed - indexed for MEDLINE]
Free Article
14.

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.

Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke M, Weingart O, Kluge S, Piper M, Rades D, Steensma DP, Djulbegovic B, Fey MF, Ray-Coquard I, Machtay M, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A.

Lancet. 2009 May 2;373(9674):1532-42. doi: 10.1016/S0140-6736(09)60502-X. Erratum in: Lancet. 2009 Jul 4-2009 Jul 10;374(9683):28.

PMID:
19410717
[PubMed - indexed for MEDLINE]
15.

Emerging topics in anaemia and cancer.

Aapro M.

Ann Oncol. 2012 Sep;23 Suppl 10:x289-93.

PMID:
22987979
[PubMed - indexed for MEDLINE]
16.

Update on safety of ESAs in cancer-induced anemia.

Glaspy J.

J Natl Compr Canc Netw. 2012 May;10(5):659-66. Review.

PMID:
22570294
[PubMed - indexed for MEDLINE]
17.

Erythropoietin in cancer patients.

Glaspy JA.

Annu Rev Med. 2009;60:181-92. doi: 10.1146/annurev.med.60.050307.110718. Review.

PMID:
18980468
[PubMed - indexed for MEDLINE]
18.

Erythropoietin or darbepoetin for patients with cancer.

Tonia T, Mettler A, Robert N, Schwarzer G, Seidenfeld J, Weingart O, Hyde C, Engert A, Bohlius J.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD003407. doi: 10.1002/14651858.CD003407.pub5. Review.

PMID:
23235597
[PubMed - indexed for MEDLINE]
19.

Erythropoiesis-stimulating agents: favorable safety profile when used as indicated.

Nowrousian MR, Dunst J, Vaupel P.

Strahlenther Onkol. 2008 Mar;184(3):121-36. doi: 10.1007/s00066-008-1841-3. Review.

PMID:
18330508
[PubMed - indexed for MEDLINE]
20.

Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis.

Tonelli M, Hemmelgarn B, Reiman T, Manns B, Reaume MN, Lloyd A, Wiebe N, Klarenbach S.

CMAJ. 2009 May 26;180(11):E62-71. doi: 10.1503/cmaj.090470. Epub 2009 Apr 30. Review. Erratum in: CMAJ. 2009 Jul 7;181(1-2):61.

PMID:
19407261
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk